MedTrace Logo

Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses

NCT06657677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-02-27

No results posted yet for this study

Summary

Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin, as well as its protein characteristics, following the administration of a single iron dose

Conditions

  • Iron Deficiency (Without Anemia)

Interventions

DIETARY_SUPPLEMENT

40mg oral iron dosing

Participants will receive a single morning oral dose of iron as Fe57-labelled ferrous sulfate

DIETARY_SUPPLEMENT

100mg oral iron dosing

Participants will receive a single morning oral dose of iron as Fe57-labelled ferrous sulfate

DIETARY_SUPPLEMENT

180mg oral iron dosing

Participants will receive a single morning oral dose of iron as Fe57-labelled ferrous sulfate

Sponsors & Collaborators

  • Jessica Rigutto

    lead OTHER

Principal Investigators

  • Nicole Stoffel, PhD · ETH Zurich

Study Design

Allocation
NA
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-25
Primary Completion
2024-12-16
Completion
2024-12-16

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06657677 on ClinicalTrials.gov